Trending...
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- Twin Flame Visions Disrupts the Industry With Record Ad Performance and Rapid User Growth
- SIMM Capital Fund Surpasses $25M Raised and $100M+ in Real Estate Assets
PHILADELPHIA, April 6, 2021 /PRNewswire/ -- Waypoint Orthopedics, Inc. today announced that its Board of Directors appointed Jeffrey F. O'Donnell, Jr. as President effective April 2, 2021.
Mr. O'Donnell joined Waypoint in January of 2021, serving as VP of Business Development and Marketing. In that role, Mr. O'Donnell has led the Company's early product development, regulatory, and business development efforts.
Chief Medical Officer and Co-Founder of Waypoint, Dr. Stephen P. Banco, M.D., said, "The Waypoint Orthopedics Board believes Jeff is the obvious choice, and we are thrilled to have him as our President. Jeff has been the driving force behind the company's operations and has essentially been functioning as the President since joining the company in January. We are confident that Jeff's insight and enthusiasm will be instrumental in bringing our product to fruition."
"I am honored and excited for the opportunity to continue to lead Waypoint with Dr. Banco and our extremely talented team. Waypoint's mission is to make vertebral fixation safer for the patient, the physician, the rep, and operating room personnel," said O'Donnell.
Prior to Waypoint, Mr. O'Donnell has been a healthcare entrepreneur operating in the emerging growth space within orthopedics, digital health, and cardiology. Earlier in his career, Mr. O'Donnell spent six years with Trice Medical in several different leadership roles. He started his healthcare career with MedImmune, Inc. He holds a B.A. from Saint Joseph's University.
More on The PennZone
About Waypoint Orthopedics:
Waypoint Orthopedics, Inc. was founded in 2020 to make vertebral fixation safer and more efficient for the patient, surgeon, and support staff. Waypoint Orthopedics' controlling stockholder is Runway Healthcare, LP - a MedTech accelerator fund.
Forward-Looking Statements
This press release contains "forward-looking statements" concerning the development of Waypoint Orthopedics products, the potential benefits and attributes of those products, and the company's expectations regarding its prospects. Forward-looking statements are subject to risks, assumptions and uncertainties that could cause actual future events or results to differ materially from such statements. These statements are made as of the date of this press release. Actual results may vary. Waypoint Orthopedics undertakes no obligation to update any forward-looking statements for any reason.
Inquires: [email protected]
Related Images
jeffrey-f-odonnell-jr.png
Jeffrey F. O'Donnell, Jr.
Jeffrey F. O'Donnell, Jr. - President, Waypoint Orthopedics.
SOURCE Waypoint Orthopedics
Mr. O'Donnell joined Waypoint in January of 2021, serving as VP of Business Development and Marketing. In that role, Mr. O'Donnell has led the Company's early product development, regulatory, and business development efforts.
Chief Medical Officer and Co-Founder of Waypoint, Dr. Stephen P. Banco, M.D., said, "The Waypoint Orthopedics Board believes Jeff is the obvious choice, and we are thrilled to have him as our President. Jeff has been the driving force behind the company's operations and has essentially been functioning as the President since joining the company in January. We are confident that Jeff's insight and enthusiasm will be instrumental in bringing our product to fruition."
"I am honored and excited for the opportunity to continue to lead Waypoint with Dr. Banco and our extremely talented team. Waypoint's mission is to make vertebral fixation safer for the patient, the physician, the rep, and operating room personnel," said O'Donnell.
Prior to Waypoint, Mr. O'Donnell has been a healthcare entrepreneur operating in the emerging growth space within orthopedics, digital health, and cardiology. Earlier in his career, Mr. O'Donnell spent six years with Trice Medical in several different leadership roles. He started his healthcare career with MedImmune, Inc. He holds a B.A. from Saint Joseph's University.
More on The PennZone
- Costa Oil - 10 Minute Oil Change Surpasses 70 Locations with Construction of San Antonio, TX Stores — Eyes Growth Via Acquisition or Being Acquired
- LaTerra and Respark Under Contract with AIMCO to Acquire a $455M, 7-Property Chicago Multifamily Portfolio
- Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
- VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
- Children Rising Appoints Marshelle A. Wilburn as New Executive Director
About Waypoint Orthopedics:
Waypoint Orthopedics, Inc. was founded in 2020 to make vertebral fixation safer and more efficient for the patient, surgeon, and support staff. Waypoint Orthopedics' controlling stockholder is Runway Healthcare, LP - a MedTech accelerator fund.
Forward-Looking Statements
This press release contains "forward-looking statements" concerning the development of Waypoint Orthopedics products, the potential benefits and attributes of those products, and the company's expectations regarding its prospects. Forward-looking statements are subject to risks, assumptions and uncertainties that could cause actual future events or results to differ materially from such statements. These statements are made as of the date of this press release. Actual results may vary. Waypoint Orthopedics undertakes no obligation to update any forward-looking statements for any reason.
Inquires: [email protected]
Related Images
jeffrey-f-odonnell-jr.png
Jeffrey F. O'Donnell, Jr.
Jeffrey F. O'Donnell, Jr. - President, Waypoint Orthopedics.
SOURCE Waypoint Orthopedics
Filed Under: Business
0 Comments
Latest on The PennZone
- Artificial Intelligence Leader Releases Children's Book on Veterans Day
- KDG Recognized on the Clutch 1000 List for 2025
- SNS Research Group has published its flagship report, "Dermatological Drugs Market: 2025–2035"
- Felicia Allen Hits #1 Posthumously with "Christmas Means Worship"
- CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
- The Rise of Experience Gifting: Families Choosing Memories Over More Stuff This Christmas
- Pittsburgh Family Law Firm Pollock Begg Elevates Two Attorneys to Partner Ranks
- Innovu Launches Auto Analysis, an AI Feature That Explains Healthcare Data in Plain Language
- Tokenized Real-World Assets: Iguabit Brings Institutional Investment Opportunities to Brazil
- MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi
- From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
- New Angles US Group Founder Alexander Harrington Receives Top U.S. Corporate Training Honor and Leads Asia-Pacific Engagements in Taiwan
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- UK Financial Ltd Sets Official 30-Day Conversion Deadline for Three Exchange Listed Tokens Ahead of Regulated Upgrade
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
- Discover the Magic of Creativity with The Balance of Brushes and Bytes
- Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case
- Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
- Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
- IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention